Carrie Brownstein
Director/Board Member bei SHATTUCK LABS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Carrie Brownstein is an Independent Director at Shattuck Labs, Inc. She previously worked as an Executive Director-Clinical Sciences Oncology at Regeneron Pharmaceuticals, Inc. and as a Senior Director-Medical at Roche Pharmaceuticals, Inc. From 2017 to 2020, she was the VP-Global Clinical Research & Development at Celgene Corp.
She was also the Chief Medical Officer at Cellectis SA from 2020 to 2022 and at Zentalis Pharmaceuticals, Inc. from 2022 to 2024.
Brownstein received her undergraduate degree from the University of Michigan and her doctorate from Tufts University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.10.2023 | 105 685 ( 0,15% ) | 2 Mio $ | 31.03.2024 | |
SHATTUCK LABS, INC.
-.--% | 01.03.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Carrie Brownstein
| Unternehmen | Position | Beginn |
|---|---|---|
| SHATTUCK LABS, INC. | Director/Board Member | 22.10.2021 |
Ehemalige bekannte Positionen von Carrie Brownstein
| Unternehmen | Position | Ende |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 19.01.2024 |
| CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 28.09.2022 |
| CELGENE | Chief Tech/Sci/R&D Officer | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2012 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Ausbildung von Carrie Brownstein
| University of Michigan | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| CELLECTIS S.A. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
